Systems and methods for the conditioning of cerebrospinal fluid
Systems and methods for treating biologic fluids are disclosed. Some disclosed embodiments may be used to filter cerebrospinal fluid (CSF) from a human or animal subject, heat CSF to a target temperature, cool CSF to a target temperature, apply light treatment to CSF, separate cells via their dielectric properties, apply spiral and/or centrifugal separation, introduce additives to target particles, and/or apply combinations thereof. The method may include the steps of withdrawing fluid comprising CSF, treating the fluid, and returning a portion of the treated fluid to the subject. During operation of the system, various parameters may be modified, such as flow rate.
1. A method for treating cerebrospinal fluid (CSF) of a human or animal subject, the method comprising the steps of:
withdrawing a volume of fluid comprising CSF from a CSF-containing space of the subject at a first flow rate;
treating the volume of fluid, wherein treating the volume of fluid comprises filtering the volume of fluid into permeate and retentate using a tangential flow filter;
measuring a characteristic of the volume of fluid using a sensor;
returning at least a portion of the treated volume of fluid to the CSF-containing space of the subject at a second flow rate;
updating a parameter of a set of operation parameters based on the measured characteristic responsive to determining that the measured characteristic passes a predetermined threshold, and
increasing a rate at which the volume of fluid passes through the tangential flow filter by diverting a portion of the permeate or retentate back through the tangential flow filter.
2. The method of claim 1 , wherein treating the volume of fluid comprises separating a first portion of the volume of fluid from a second portion of the volume of fluid by applying a non-uniform electric field to the volume of fluid.
3. The method of claim 1 , wherein treating the volume of fluid comprises separating a first portion of the volume of fluid from a second portion of the volume of fluid by passing the volume of fluid through a hydrocyclone.
4. The method of claim 1 , wherein treating the volume of fluid comprises inactivating a target microorganism by heating or cooling the volume of fluid to a target temperature.
5. The method of claim 4 , wherein the target microorganism is C. neoformans or C. gattii and the target temperature is between approximately 40° C. and approximately 45° C.
6. The method of claim 1 , wherein treating the volume of fluid comprises inactivating a target microorganism by applying a dose of ultraviolet radiation to the volume of fluid.
7. The method of claim 6 , wherein the microorganism is an organism that causes meningitis and the dose is about 5 mJ/cm 2 to about 8 mJ/cm 2 .
8. The method of claim 6 , wherein the ultraviolet radiation has a wavelength of about 400 nm to about 100 nm.
9. The method of claim 1 , further comprising introducing an additive to the volume of fluid.
10. The method of claim 9 , wherein the additive is a gold micro or nano particle.
11. The method of claim 9 , wherein the additive is configured to preferentially bind to a target material within the volume of fluid to modify how the material is treated.
12. The method of claim 11 , wherein the treatment includes filtration of the volume of CSF; and wherein the additive is configured to improve the effectiveness of the treatment step by binding to the target material to cause the target material to be more easily filtered by the filter.
13. The method of claim 1 , wherein treating the volume of fluid comprises targeting a predetermined target.
14. The method of claim 13 , wherein the target is a protein selected from a group consisting of EGF, Eotaxin, E-selectin, fas ligand, FGF2, Flt3 lig, fractalkine, G-CSF, GM-CSF, GRO, ICAM, IFNa2, IFNg, IL10, IL12p40, IL12p70, IL13, IL15, IL17, IL1a, IL1b, IL1ra, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, integrins, IP10, L-selectin, MCP1, MCP3, MDC, MIP1a, MIP1b, PDGF-AA, PDGF-AAAB, P-selectin, RANTES, sCD40L, sIL2R, TGFa, TNF, TNFb, VCAM, and VEGF.
15. The method of claim 13 , wherein the target is a polysaccharide capsule.
16. The method of claim 1 wherein the threshold is a volume of removed CSF that is an amount greater than 15 milliliters per hour.
17. A method for treating cerebrospinal fluid (CSF) of a human or animal subject, the method comprising the steps of:
withdrawing a volume of fluid comprising CSF from a CSF-containing space of the subject at a first flow rate;
treating the volume of fluid, wherein treating the volume of fluid comprises filtering the volume of fluid into permeate and retentate using a tangential flow filter;
measuring a characteristic of the volume of fluid using a sensor;
returning at least a portion of the treated volume of fluid to the CSF-containing space of the subject at a second flow rate;
updating a parameter of a set of operation parameters based on the measured characteristic responsive to determining that the measured characteristic passes a predetermined threshold, and
inhibiting microorganism growth on the tangential flow filter by heating of the filter.
18. A method for treating cerebrospinal fluid (CSF) of a human or animal subject, the method comprising the steps of:
withdrawing a volume of fluid comprising CSF from a CSF-containing space of the subject at a first flow rate;
treating the volume of fluid;
measuring a characteristic of the volume of fluid using a sensor;
returning at least a portion of the treated volume of fluid to the CSF-containing space of the subject at a second flow rate; and
updating a parameter of a set of operation parameters based on the measured characteristic responsive to determining that the measured characteristic passes a predetermined threshold,
wherein treating the volume of fluid comprises one or more of:
filtering the volume of fluid into permeate and retentate using a tangential flow filter;
separating a first portion of the volume of fluid from a second portion of the volume of fluid by applying a non-uniform electric field to the volume of fluid; and
separating a first portion of the volume of fluid from a second portion of the volume of fluid by passing the volume of fluid through a hydrocyclone; and
wherein treating the volume of fluid further comprises one or more of
inactivating a target microorganism by heating or cooling the volume of fluid to a target temperature; and
inactivating a target microorganism by applying a dose of ultraviolet radiation to the volume of fluid.